[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351183-105":59,"doc-detail-351183-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","pdha1acetylation-signaling-suppresses-cuproptosis-to-attenuate-anti-androgen-effect-in-prostate-cancer","PDHA1–acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer","","Castration-resistant prostate cancer (CRPC) persists despite androgen deprivation therapy, and resistance to enzalutamide (Enz) drives poor outcomes. Cuproptosis, a copper-dependent regulated cell death program, links disrupted copper metabolism to therapeutic failure. This study identifies PDHA1 as a key regulator of cuproptosis via acetyl-CoA–dependent histone acetylation, including H3K27ac. PDHA1 elevates acetyl-CoA, upregulates SLC7A11 to increase cysteine and glutathione (GSH), and GSH chelates intracellular copper, suppressing cuproptosis and reducing Enz sensitivity. The PDHA1–acetyl-CoA–H3K27ac–SLC7A11/GSH axis supports targeting PDHA1 to reactivate cuproptosis and overcome Enz resistance in CRPC.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pdha1acetylation-signaling-suppresses-cuproptosis-to-attenuate-anti-androgen-effect-in-prostate-cancer/351183/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pdha1acetylation-signaling-suppresses-cuproptosis-to-attenuate-anti-androgen-effect-in-prostate-cancer/351183.png","ImageObject",300,407,{"name":92,"@type":93},"Aurelia","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does enzalutamide resistance play in castration-resistant prostate cancer?","Question",{"text":112,"@type":113},"Enzalutamide resistance allows CRPC tumors to continue growing despite androgen deprivation. The document highlights multiple resistance-driving mechanisms and the resulting poor prognosis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What is cuproptosis and why is it relevant to CRPC?",{"text":117,"@type":113},"Cuproptosis is a copper-dependent form of regulated cell death marked by mitochondrial dysfunction and protein aggregation. The text links altered copper metabolism to disease progression and treatment failure.",{"name":119,"@type":110,"acceptedAnswer":120},"How does PDHA1 acetylation-related signaling suppress cuproptosis?",{"text":121,"@type":113},"PDHA1 increases intracellular acetyl-CoA, enhances H3K27 acetylation, and upregulates SLC7A11 to boost cysteine uptake and glutathione (GSH) synthesis. GSH chelates labile intracellular copper, suppressing cuproptosis and reducing cellular sensitivity to Enz.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351183,1790315111,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068365,"https://ap-avatar.wpscdn.com/avatar/10000253d8d9f28188e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1794309523707217728","[www.nature.com/cddis](www.nature.com/cddis)  \nARTICLE OPEN   \nPDHA1–acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer  \nRuilin Zhuang1,2,3,7, Qianghua Zhou2,7, Bisheng Cheng4,7, Shirong Peng1,3,7, Zhi Xiong 1,3, Zhaoxiang Xie 1,3, Weilong Lin1,3, Tong Su 1,3, Zean Li1,3, Kai Yao 2, Zhiming Wu2 ✉, Hai Huang 1,3,5,6 ✉ and Kaiwen Li 1,3,5 ✉  \n© The Author(s) 2026  \nINTRODUCTION  \nCastration-resistant prostate cancer (CRPC) represents an advanced and aggressive stage of the disease, characterized by continued tumor growth despite androgen deprivation therapy (ADT), which targets testosterone production [1, 2] . The emergence of resistance to hormonal therapies and the associated poor prognosis underscore the urgent need for innovative therapeutic approaches. Enzalutamide (Enz), a secondgeneration androgen receptor inhibitor, initially provides clinical beneﬁts by blocking androgen receptor signaling in CRPC patients [3] . However, resistance inevitably arises, driven by mechanisms such as androgen receptor mutations, alternative splicing, and activation of compensatory signaling pathways [4–7] . As a result, current research is focused on uncovering the molecular mechanisms underlying this resistance and developing innovative strategies to overcome drug resistance in CRPC. Beyond AR-centric mechanisms, there is growing interest in non-AR pathways and their potential impact on Enz resistance, with efforts aimed at identifying actionable targets for translational intervention [8–10] . In this context, exploration of regulated cell-death modalities in CRPC has accelerated, highlighting emerging links between celldeath programs and therapeutic response [11–13] .  \nCuproptosis, a recently identiﬁed copper-dependent form of regulated cell death (RCD), is marked by mitochondrial dysfunction and protein aggregation triggered by elevated intracellular  \ncopper levels [14] . This distinct pathway presents a promising therapeutic target in tumor with disrupted copper metabolism, including CRPC. In CRPC, elevated copper levels and androgenmediated copper uptake have been observed, linking copper dysregulation to disease progression and resistance to treatments [15–17] . Copper metabolism not only promotes tumor growth but also contributes to therapeutic failure [18–20] . As Enz resistance is often driven by alterations in androgen receptor pathways, targeting cuproptosis offers a novel strategy to bypass these mechanisms [3] . Preclinical studies suggest that combining copper ionophores with Enz may selectively induce cell death in CRPC cells by exploiting copper accumulation, providing a new therapeutic approach for overcoming drug resistance in advanced PCa [21] .  \nRecent advances have identiﬁed pyruvate dehydrogenase E1 alpha subunit (PDHA1) as a critical regulator of cuproptosis through genome-wide CRISPR/Cas9 screening. PDHA1 encodes the E1 α1 subunit of the pyruvate dehydrogenase complex (PDH), a key enzyme in the tricarboxylic acid (TCA) cycle responsible for converting pyruvate into acetyl-CoA. Although the precise role of PDHA1 in cuproptosis remains incompletely understood, evidence suggests its involvement in epigenetic regulation through modulation of intracellular acetyl-CoA levels [22] . Fluctuations in acetyl-CoA directly modulate histone acetylation, including histone H3K27 acetylation (H3K27ac), thereby rewiring  \n1Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. 2Department of Urology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in Southern China; Collaborative Innovation Center of Cancer Medicine, Guangzhou, China. 3Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China. 4Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China. 5Guangdong Provincial Clinical Research C","cbCainrkKKVNZFdm","https://ap.wps.com/l/cbCainrkKKVNZFdm","pdf",5940492,15,"English","# Introduction\n## Enzalutamide resistance and need for new mechanisms\n## Cuproptosis and copper dysregulation in CRPC\n## PDHA1, acetyl-CoA, and histone acetylation\n# Results and mechanistic model\n## PDHA1 elevates acetyl-CoA and H3K27ac\n## SLC7A11/GSH increases and copper chelation suppresses cuproptosis\n## Therapeutic rationale: targeting PDHA1 to overcome Enz resistance","[{\"question\":\"What role does enzalutamide resistance play in castration-resistant prostate cancer?\",\"answer\":\"Enzalutamide resistance allows CRPC tumors to continue growing despite androgen deprivation. The document highlights multiple resistance-driving mechanisms and the resulting poor prognosis.\"},{\"question\":\"What is cuproptosis and why is it relevant to CRPC?\",\"answer\":\"Cuproptosis is a copper-dependent form of regulated cell death marked by mitochondrial dysfunction and protein aggregation. The text links altered copper metabolism to disease progression and treatment failure.\"},{\"question\":\"How does PDHA1 acetylation-related signaling suppress cuproptosis?\",\"answer\":\"PDHA1 increases intracellular acetyl-CoA, enhances H3K27 acetylation, and upregulates SLC7A11 to boost cysteine uptake and glutathione (GSH) synthesis. GSH chelates labile intracellular copper, suppressing cuproptosis and reducing cellular sensitivity to Enz.\"}]","PDHA1–acetylation signaling suppresses cuproptosis to attenuate anti-androgen effect in prostate cancer | PDF",1790092955,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/abc0964288a20927a54cd2cf49ca0e41.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d306107ff19ac14daad9d6361b4266f4.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3fe62c2156a7fe66e612f622e81ad990.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/463192b472394be0f57b8c77aa6cc8cd.webp",980,1301]